1-11 of 11
Jonathan Kaufman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

How I treat high-risk myeloma

Clinical Trials & Observations
Sagar Lonial, Lawrence H. Boise, Jonathan Kaufman
Journal: Blood
Blood (2015) 126 (13): 1536–1543.
https://doi.org/10.1182/blood-2015-06-653261
Published: 2015
Journal Articles

Platelet and Fibrin Alterations on Thromboelastography in Children Undergoing Congenital Cardiac Surgery with Cardiopulmonary Bypass

Kim S. John, MD, Elizabeth Villalobos-Menuey, MS, Matthew Hathaway, Abimbola Onasoga, PhD, Jonathan Kaufman, MD, Eduardo DaCruz, MD, Jorge DiPaola, MD, Marilyn J. Manco-Johnson, MD
Journal: Blood
Blood (2014) 124 (21): 4194.
https://doi.org/10.1182/blood.V124.21.4194.4194
Published: 2014
Journal Articles

Phase 1/2 Study of Elotuzumab in Combination with Lenalidomide and Low Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma: Interim Results.

Sagar Lonial, Ravi Vij, Jean-Luc Harousseau, Thierry Facon, Jonathan Kaufman, Amitabha Mazumder, Philippe Moreau, Xavier Leleu, John Fry, Anil Singhal, Sundar Jagannath
Journal: Blood
Blood (2009) 114 (22): 432.
https://doi.org/10.1182/blood.V114.22.432.432
Published: 2009
Journal Articles

A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration.

Sagar Lonial, MD, Jonathan Kaufman, MD, Claire Torre, Amelia Langston, Mary J. Lechowicz, Christopher Flowers, Stephanie McMillan, Heather Renfroe, Leonard T Heffner, Edmund K Waller
Journal: Blood
Blood (2008) 112 (11): 3332.
https://doi.org/10.1182/blood.V112.11.3332.3332
Published: 2008
Journal Articles

A Phase I MMRC Clinical Trial Testing the Combination of Bortezomib and Tipifarnib in Relapsed/Refractory Multiple Myeloma

Sagar Lonial, MD, Dixil Francis, Chatchada Karanes, Suzanne Trudel, Donna E. Reece, MD, Amrita Krishnan, Marc Buacharern, Renee Smith, Faraz Zaman, Engin Gul, Akari M. Dollard, Donald Harvey, Jonathan Kaufman
Journal: Blood
Blood (2008) 112 (11): 3706.
https://doi.org/10.1182/blood.V112.11.3706.3706
Published: 2008
Journal Articles

Ara-C, Topotecan, and Gemtuzumab Ozogamicin [ATGO] Is An Effective Induction Regimen for Advanced MDS and Secondary or Relapsed AML: Analysis of a Phase I/II Study

Amelia A Langston, MD, Sujatha Murali, MD, Stephanie McMillan, RN, Leonard T. Heffner, MD, Sagar Lonial, MD, Edmund K. Waller, MD, PhD, Christopher R. Flowers, MD, Jonathan Kaufman, MD, Morgan L. McLemore, MD, Rajni Sinha, MD, Mary J Lechowicz, MD, H. Jean Khoury, MD, Elliott F. Winton, MD
Journal: Blood
Blood (2008) 112 (11): 3644.
https://doi.org/10.1182/blood.V112.11.3644.3644
Published: 2008
Journal Articles

First Trial of Humanized Anti-CD74 Monoclonal Antibody (MAb), Milatuzumab, in Multiple Myeloma

Jonathan Kaufman, MD, Ruben Niesvizky, MD, Edward A. Stadtmauer, MD, Asher Chanan-Khan, MD, David Siegel, MD, PhD, Heather Horne, Nick Teoh, PhD, Matthew J. Leoni, MD, William A Wegener, MD, PhD, David M. Goldenberg, ScD, MD
Journal: Blood
Blood (2008) 112 (11): 3697.
https://doi.org/10.1182/blood.V112.11.3697.3697
Published: 2008
Journal Articles

Impact of Prior Lenalidomide Treatment on Peripheral Blood Stem Cell (PBSC) Mobilization in Untreated Multiple Myeloma (MM) Patients.

Amitabha Mazumder, MD, Jonathan Kaufman, MD, Sagar Lonial, MD, Sundar Jagannath, MD, David Vesole, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3612.
https://doi.org/10.1182/blood.V110.11.3612.3612
Published: 2007
Journal Articles

A Multiple Myeloma Research Consortium (MMRC) Multicenter Phase I Trial of Perifosine (KRX-0401) in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (MM): Updated Results.

Andrzej Jakubowiak, Todd Zimmerman, Melissa Alsina, Paul Richardson, Jonathan Kaufman, T. Kendall, C. Brozo, A. McAllister, C. Leister, T. Hideshima, P. Sportelli, L. Gardner, R. Birch, I.C. Henderson, K. Giusti, Kenneth Anderson
Journal: Blood
Blood (2007) 110 (11): 1169.
https://doi.org/10.1182/blood.V110.11.1169.1169
Published: 2007
Journal Articles

A Randomized Phase I Trial of Melphalan + Bortezomib as Conditioning for Autologous Transplant for Myeloma: The Effect of Sequence of Administration.

Sagar Lonial, MD, Jonathan Kaufman, MD, Amelia A. Langston, MD, Leonard T. Heffner, MD, Claire Torre, Mary J. Lechowicz, MD, Christopher Flowers, MD, Stephanie McMillan, RN, Michael Arnold, Ned K. Waller, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 949.
https://doi.org/10.1182/blood.V110.11.949.949
Published: 2007
Journal Articles

T Cell Reconstitution in First 200 Days Post Transplantation Predicts Long Term Survival in Allogeneic Hematopoetic Progenitor Cell Transplantation (HPCT).

Laura Vann, Milcah Larks, MD, Christopher Flowers, MD, Sagar Lonial, MD, Jonathan Kaufman, MD, Mary Jo Lechowicz, MD, Amelia A. Langston, MD, Jean Khoury, MD, Ned Waller, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 3224.
https://doi.org/10.1182/blood.V108.11.3224.3224
Published: 2006